The Week Ahead: Fed...
Health Care: Drugs
Alexza Pharmaceuticals Inc. (ALXA: NASDAQ)
$0.36 0.00 | -1.37%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.36 |
| 52 Week High | 1.91 |
| 52 Week Low | 0.35 |
| Avg. Daily Vol. (Mil) | 1.62 |
| Beta (3 year) | 1.40 |
| Share Related Items | |
| Mkt Cap (Mil) | 42.69 |
| Shares Out (Mil) | 118.59 |
| Float (Mil) | 107.96 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.00 |
| Current Ratio | 1.40 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 1.23 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 6.79 |
| Price/Book | 4.83 |
| Price/Cash Flow | -1.40 |
| Per Share Data | |
| Earnings | -0.49 |
| Sales | 0.05 |
| Book Value | 0.07 |
| Cash Flow | -0.26 |
| Business Summary | |
|---|---|
| Alexza Pharmaceuticals, Inc. is a pharmaceutical development company focused on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. | |
| General Information | |
| 2091 Stierlin Court
Mountain View, CA 94043 |
|
| www.alexza.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 44 | |
| CEO: Thomas B. King | |
| Short Interest | |
| Current Month (Mil) | 4.21 |
| Previous Month (Mil) | 0.77 |
| Short Interest Ratio (Days) | 1.60 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -66.60 |
| Return on Investments | -406.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ALXA
- Portfolio NameUser Type
- Uservlady 1
- ContributorStocks With Big Insider Buy...
- UserSMITTY
- ContributorBarron's Insider Purchases ...
- UserHi Potential
- UserRAPTOR SPRTD RED-03110081643
- UserScottrade 20K
- UserBburn Portfolio 1
- UserRatBastard Portfolio 1
- Userpornholio
Latest ALXA Headlines from TheStreet
- Friday's Top 10 Articles, Videos on TheStreet 05.04.12 | 01:05 pm
- Alexza Stock Gaps Down On Today's Open (ALXA) 05.04.12 | 09:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- 26 Drugs Facing FDA Approval in 2012 05.02.12 | 01:05 pm
- The Next Big Thing In Biotech: Alexza
04.13.12 | 06:04 am - Alexza Pharmaceuticals Inc. Stock Downgraded (ALXA) 02.24.12 | 05:02 am
- Alexza Stock Gaps Down On Today's Open (ALXA) 02.17.12 | 08:02 am
- 5 Stocks Insiders Are Loading Up On 01.26.12 | 12:01 pm
- Alexza Stock Gaps Up On Today's Open (ALXA) 01.03.12 | 11:01 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
Press Releases for ALXA
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Alexza Pharmaceuticals Inc. - PR Newswire 05.07.12 | 08:05 am
- Alexza And Grupo Ferrer Amend Adasuve⢠Partnership - PR Newswire 03.07.12 | 04:03 pm
- Alexza To Announce 2011 Year-End Financial Results On Monday, March 12, 2012 - PR Newswire 03.05.12 | 09:03 am
- Alexza Prices $22 Million Public Offering - PR Newswire 02.17.12 | 07:02 am
- Alexza Announces Proposed Public Offering Of Common Stock And Warrants - PR Newswire 02.16.12 | 06:02 pm
- Alexza Pharmaceuticals Receives Day 80 Assessment Report For ADASUVE (Staccato® Loxapine) MAA - PR Newswire 02.13.12 | 08:02 am
- Alexza Retains Lazard To Explore Strategic Options - PR Newswire 12.16.11 | 08:12 pm
- FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval Of Alexza's ADASUVE⢠- PR Newswire 12.13.11 | 05:12 am
- Alexza Pharmaceuticals To Present At The Lazard Capital Markets 8th Annual Healthcare Conference - PR Newswire 11.02.11 | 09:11 am
- Alexza To Announce 2011 Third Quarter Financial Results On Monday, November 7, 2011 - PR Newswire 10.27.11 | 06:10 pm
Partner Headlines for ALXA
- Benzinga's Microcap Movers for Friday May 4, 2012 - Benzinga 05.05.12 | 12:05 pm
- 6 Biotech Stocks With Huge Potential In May - Seeking Alpha 04.11.12 | 08:04 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- Alexza and Grupo Ferrer Amend Adasuve Partnership Alexza and Grupo Ferrer Amend Adasuve Partnership; Ferrer to Purchase 2.42M Shares of Alexza Common Stock for $1.24 per Share - Benzinga 03.07.12 | 04:03 pm
- Analysis Of Institutional 5% Ownership Filings On Tuesday And Wednesday - Seeking Alpha 01.05.12 | 08:01 am
- Microcap Movers for Friday December 9, 2011 - Benzinga 12.09.11 | 06:12 pm
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Company News for October 5, 2011 - Corporate Summary - Zacks 10.05.11 | 10:10 am
- Alexza Pharmaceuticals Nears Daily High; Ready to Breakout - Benzinga 09.07.11 | 01:09 pm
- Alexza Hopes New NDA Submission Will Relieve Agitation - Benzinga 08.17.11 | 01:08 pm
